Risperidone ER 50mg Inj Susp Kit

Manufacturer TEVA PHARMACEUTICALS Active Ingredient Risperidone Injection (IM)(ris PER i done) Pronunciation ris PER i done
WARNING: There is a higher chance of death in older adults who take this drug for mental problems caused by dementia. Most of the deaths were linked to heart disease or infection. This drug is not approved to treat mental problems caused by dementia. @ COMMON USES: It is used to treat schizophrenia.It is used to treat bipolar disorder.It may be given to you for other reasons. Talk with the doctor.
🏷️
Drug Class
Atypical Antipsychotic
🧬
Pharmacologic Class
Serotonin-Dopamine Antagonist (SDA)
🀰
Pregnancy Category
Category C
βœ…
FDA Approved
Oct 2003
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Risperidone extended-release injection is a long-acting medication given by injection every two weeks. It's used to treat mental health conditions like schizophrenia and bipolar disorder. It helps to balance certain chemicals in the brain, which can reduce symptoms like hallucinations, delusions, and mood swings. Because it's a long-acting injection, it helps ensure you get a steady dose of medication without needing to take pills every day.
πŸ“‹

How to Use This Medicine

To use this medication correctly, follow your doctor's instructions and carefully read all accompanying information. Take this medication exactly as directed, and adhere to all guidelines provided. This drug is administered via intramuscular injection.

For storage and disposal, consult with your doctor, nurse, or pharmacist to determine the best approach for storing this medication at home, if necessary.

If you miss a dose, contact your doctor promptly to receive guidance on the appropriate course of action.
πŸ’‘

Lifestyle & Tips

  • Avoid alcohol and other CNS depressants, as they can increase drowsiness and dizziness.
  • Be cautious when driving or operating machinery until you know how the medication affects you, due to potential for sedation or dizziness.
  • Maintain a healthy diet and exercise regularly to help manage potential weight gain and metabolic changes.
  • Stay hydrated, especially in hot weather, as this medication can affect body temperature regulation.
  • Inform your healthcare provider about all medications, supplements, and herbal products you are taking.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: Initial dose: 25 mg IM every 2 weeks. Maintenance dose: 25 mg, 37.5 mg, or 50 mg IM every 2 weeks. Oral risperidone should be co-administered for the first 3 weeks until the main release of risperidone from the injection site has begun.
Dose Range: 25 - 50 mg

Condition-Specific Dosing:

schizophrenia: 25 mg IM every 2 weeks, increasing to 37.5 mg or 50 mg if needed, after 4 weeks. Max 50 mg every 2 weeks.
bipolar_disorder_manic_or_mixed_episodes: 25 mg IM every 2 weeks, increasing to 37.5 mg or 50 mg if needed, after 4 weeks. Max 50 mg every 2 weeks.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established (Safety and efficacy not established for IM extended-release in pediatric patients. Oral risperidone has specific pediatric indications.)
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment for IM extended-release, but caution advised. For oral risperidone, consider lower initial doses.
Moderate: Consider lower initial doses (e.g., 12.5 mg IM every 2 weeks) and titrate cautiously. Oral risperidone initial dose 0.5 mg BID.
Severe: Consider lower initial doses (e.g., 12.5 mg IM every 2 weeks) and titrate cautiously. Oral risperidone initial dose 0.5 mg BID.
Dialysis: Not specifically studied for IM extended-release. For oral risperidone, dose adjustments are needed; risperidone is not significantly removed by hemodialysis.

Hepatic Impairment:

Mild: No specific adjustment for IM extended-release, but caution advised. For oral risperidone, consider lower initial doses.
Moderate: Consider lower initial doses (e.g., 12.5 mg IM every 2 weeks) and titrate cautiously. Oral risperidone initial dose 0.5 mg BID.
Severe: Consider lower initial doses (e.g., 12.5 mg IM every 2 weeks) and titrate cautiously. Oral risperidone initial dose 0.5 mg BID.

Pharmacology

πŸ”¬

Mechanism of Action

Risperidone is a selective monoaminergic antagonist with high affinity for serotonin 5-HT2A and dopamine D2 receptors. It also antagonizes alpha1-adrenergic and, to a lesser extent, H1 histaminergic and alpha2-adrenergic receptors. Antagonism at other receptors is less potent. The therapeutic effect in schizophrenia is believed to be mediated through a combination of D2 and 5-HT2A receptor antagonism.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Not directly applicable for IM extended-release as it's a sustained release. After a single IM injection, risperidone is slowly released from the microspheres. The main release phase begins approximately 3 weeks after injection and lasts for about 4 to 6 weeks.
Tmax: Risperidone: Median Tmax is 4-5 days after the first injection, and 3-6 days after subsequent injections. 9-hydroxyrisperidone: Median Tmax is 4-7 days after the first injection, and 4-8 days after subsequent injections.
FoodEffect: Not applicable for IM injection.

Distribution:

Vd: 1-2 L/kg (for oral risperidone)
ProteinBinding: Risperidone: approximately 90%; 9-hydroxyrisperidone: approximately 77%
CnssPenetration: Yes

Elimination:

HalfLife: Risperidone: approximately 3 days (for oral); 9-hydroxyrisperidone: approximately 21 days (for oral). For IM extended-release, the apparent half-life is 4.5 to 6 days for risperidone and 9-hydroxyrisperidone combined, due to the slow release from the injection site.
Clearance: Not readily quantifiable for IM extended-release due to sustained release.
ExcretionRoute: Renal (approximately 70%), Fecal (approximately 14%)
Unchanged: Less than 1% (risperidone); approximately 35-45% (9-hydroxyrisperidone) in urine.
⏱️

Pharmacodynamics

OnsetOfAction: Delayed for IM extended-release; therapeutic levels are typically achieved after 3 weeks, requiring oral risperidone co-administration during this period.
PeakEffect: Peak plasma concentrations occur 4-6 weeks after injection.
DurationOfAction: 2 weeks (due to the bi-weekly injection schedule, but drug levels are sustained for longer).

Safety & Warnings

⚠️

BLACK BOX WARNING

Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Risperidone is not approved for the treatment of patients with dementia-related psychosis.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood sugar, including:
+ Confusion
+ Feeling sleepy
+ Unusual thirst or hunger
+ Passing urine more often
+ Flushing
+ Fast breathing
+ Breath that smells like fruit
Severe dizziness or passing out
Changes in behavior or mood
Shakiness, trouble moving around, or stiffness
Urination problems, such as inability to pass urine or changes in urine output
Trouble swallowing or speaking
Difficulty focusing
Seizures
Changes in eyesight
Shortness of breath
Drooling
Feeling extremely hot or cold
Hormonal changes, such as:
+ Enlarged breasts
+ Nipple discharge
+ Erectile dysfunction or changes in menstrual cycle
Sexual problems, including:
+ Decreased interest in sex
+ Ejaculation problems
Prolonged or painful erections (lasting more than 4 hours), which can lead to lasting sexual dysfunction if left untreated
Neuroleptic malignant syndrome (NMS), a rare but potentially life-threatening condition, characterized by:
+ Fever
+ Muscle cramps or stiffness
+ Dizziness
+ Severe headache
+ Confusion
+ Changes in thinking or heartbeat
+ Excessive sweating
Low white blood cell count, which can increase the risk of infection; if you have a history of low white blood cell count, inform your doctor and seek medical attention if you experience:
+ Fever
+ Chills
+ Sore throat
Tardive dyskinesia, a severe muscle problem, which may cause:
+ Uncontrollable body movements
+ Tongue, face, mouth, or jaw problems, such as tongue sticking out, puffing cheeks, mouth puckering, or chewing

Other Possible Side Effects

While many people may not experience any side effects or only minor ones, it's essential to be aware of the following potential side effects:

Weight gain
Restlessness
Dizziness, sleepiness, tiredness, or weakness
Anxiety
Gastrointestinal problems, such as:
+ Constipation
+ Diarrhea
+ Stomach pain
+ Upset stomach
+ Vomiting
Heartburn
Dry mouth
Changes in appetite
Common cold symptoms
Headache
Sleep disturbances
Back, muscle, arm, or leg pain
Irritation at the injection site

If you experience any of these side effects or have concerns, contact your doctor or seek medical attention. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Fever, muscle stiffness, confusion, sweating, or rapid heart rate (signs of Neuroleptic Malignant Syndrome - NMS)
  • Uncontrolled movements of the face, tongue, or other body parts (signs of tardive dyskinesia)
  • Severe dizziness or fainting, especially when standing up (orthostatic hypotension)
  • Difficulty swallowing or breathing
  • Seizures
  • Signs of high blood sugar (increased thirst, frequent urination, increased hunger, weakness)
  • Signs of high cholesterol (no direct symptoms, but important to monitor)
  • Breast enlargement, milk production, or menstrual changes in women; breast enlargement or sexual dysfunction in men (signs of hyperprolactinemia)
  • Injection site reactions (severe pain, swelling, redness, lumps that don't go away)
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced as a result of the allergy.
All medications you are currently taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This information will help your doctor and pharmacist assess potential interactions between this medication and other substances you are taking.
* Any existing health problems, as this medication may interact with certain conditions.

To ensure your safety, it is crucial to verify that this medication can be taken safely with all your other medications and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. This will help ensure your safety and prevent any potential interactions with other treatments.

When starting this medication, be cautious when performing tasks that require your full attention, such as driving, until you understand how it affects you. To minimize the risk of dizziness or fainting, get up slowly from a sitting or lying position, and be careful when navigating stairs.

You may not experience the full effects of this medication for several weeks. Additionally, be aware that medications like this one have been associated with increased risks of high blood sugar, diabetes, high cholesterol, and weight gain, which can contribute to heart and brain blood vessel disease.

As directed by your doctor, monitor your blood sugar levels regularly. Also, follow your doctor's instructions for having blood work checked, and discuss any concerns or questions you may have with your doctor.

It is recommended to avoid consuming alcohol while taking this medication. Before using marijuana, cannabis, or any prescription or over-the-counter drugs that may cause drowsiness, consult with your doctor to ensure safe use.

In hot weather or during physical activity, be mindful of your fluid intake to prevent dehydration. Drink plenty of fluids to stay hydrated.

This medication may cause dizziness, drowsiness, and impaired balance, which can increase the risk of falls and related injuries, such as fractures. Older adults with dementia who take medications like this one have a higher risk of experiencing strokes, which can be fatal. Note that this medication is not approved for treating dementia-related mental health issues.

If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. This medication may also affect fertility, but this effect is reversible once the medication is stopped. If you have concerns, discuss them with your doctor.

If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor. You will need to discuss the potential benefits and risks of this medication to both you and your baby. Taking this medication during the third trimester of pregnancy may cause side effects or withdrawal symptoms in the newborn.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Drowsiness
  • Sedation
  • Tachycardia (fast heart rate)
  • Hypotension (low blood pressure)
  • Extrapyramidal symptoms (involuntary movements, muscle stiffness)
  • QT prolongation
  • Seizures

What to Do:

Seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. Management is supportive, including maintaining an open airway, ensuring adequate oxygenation and ventilation, and monitoring cardiovascular function (ECG, blood pressure). Activated charcoal may be considered if ingestion was recent. There is no specific antidote.

Drug Interactions

πŸ”΄

Major Interactions

  • Strong CYP2D6 inhibitors (e.g., paroxetine, fluoxetine): May increase risperidone and 9-hydroxyrisperidone levels. Consider dose reduction.
  • Strong CYP3A4 inducers (e.g., carbamazepine, rifampin, phenytoin): May decrease risperidone and 9-hydroxyrisperidone levels. May require dose increase.
  • Drugs that prolong QT interval (e.g., Class IA and III antiarrhythmics, some antipsychotics, moxifloxacin): Increased risk of arrhythmias.
  • CNS depressants (e.g., alcohol, opioids, benzodiazepines): Additive sedative effects.
  • Antihypertensives: Enhanced hypotensive effects due to alpha-adrenergic blockade.
🟑

Moderate Interactions

  • Moderate CYP2D6 inhibitors (e.g., quinidine): May increase risperidone levels.
  • Moderate CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): May increase risperidone levels.
  • Levodopa and dopamine agonists: Risperidone may antagonize their effects.
  • Cimetidine, ranitidine: May increase risperidone bioavailability (oral).

Monitoring

πŸ”¬

Baseline Monitoring

Weight and BMI

Rationale: Risk of weight gain and metabolic changes.

Timing: Prior to initiation

Fasting Plasma Glucose (FPG) or HbA1c

Rationale: Risk of hyperglycemia and diabetes.

Timing: Prior to initiation

Lipid Panel (Fasting)

Rationale: Risk of dyslipidemia.

Timing: Prior to initiation

Blood Pressure and Heart Rate

Rationale: Risk of orthostatic hypotension and tachycardia.

Timing: Prior to initiation

ECG (Electrocardiogram)

Rationale: Risk of QT prolongation, especially in patients with cardiac disease or on other QT-prolonging drugs.

Timing: Prior to initiation (consider if risk factors present)

Abnormal Involuntary Movement Scale (AIMS)

Rationale: Baseline assessment for tardive dyskinesia.

Timing: Prior to initiation

Prolactin Levels

Rationale: Risk of hyperprolactinemia.

Timing: Prior to initiation (consider if symptoms or risk factors present)

Renal and Hepatic Function Tests

Rationale: To guide dosing in impaired patients.

Timing: Prior to initiation

πŸ“Š

Routine Monitoring

Weight and BMI

Frequency: Monthly for first few months, then quarterly

Target: Maintain healthy range

Action Threshold: Significant weight gain (e.g., >5% baseline) warrants intervention.

Fasting Plasma Glucose (FPG) or HbA1c

Frequency: At 3 months, then annually

Target: FPG <100 mg/dL, HbA1c <5.7%

Action Threshold: Elevated levels warrant further investigation and intervention.

Lipid Panel (Fasting)

Frequency: At 3 months, then annually

Target: LDL <100 mg/dL, HDL >40 mg/dL (men), >50 mg/dL (women), Triglycerides <150 mg/dL

Action Threshold: Dyslipidemia warrants intervention.

Blood Pressure and Heart Rate

Frequency: At each visit

Target: Normal range

Action Threshold: Orthostatic hypotension or significant changes warrant intervention.

Abnormal Involuntary Movement Scale (AIMS)

Frequency: Every 6-12 months

Target: No abnormal movements

Action Threshold: Emergence of abnormal movements warrants assessment for tardive dyskinesia.

Extrapyramidal Symptoms (EPS) assessment

Frequency: At each visit

Target: No EPS

Action Threshold: Emergence of EPS (e.g., akathisia, dystonia, parkinsonism) warrants intervention.

Prolactin Levels

Frequency: Periodically, if symptomatic (e.g., galactorrhea, amenorrhea, gynecomastia, sexual dysfunction)

Target: Normal range

Action Threshold: Symptomatic hyperprolactinemia warrants intervention.

πŸ‘οΈ

Symptom Monitoring

  • Psychotic symptoms (hallucinations, delusions, disorganized thought)
  • Mood stabilization (for bipolar disorder)
  • Sedation/somnolence
  • Dizziness/orthostatic hypotension
  • Weight changes
  • Movement disorders (tremor, rigidity, akathisia, dystonia, tardive dyskinesia)
  • Sexual dysfunction
  • Menstrual irregularities/galactorrhea
  • Injection site reactions (pain, swelling, redness)
  • Signs of Neuroleptic Malignant Syndrome (NMS): fever, muscle rigidity, altered mental status, autonomic instability

Special Patient Groups

🀰

Pregnancy

Category C. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Neonates exposed to antipsychotic drugs during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms following delivery.

Trimester-Specific Risks:

First Trimester: Limited data, but generally considered low risk for major malformations based on overall antipsychotic data.
Second Trimester: Continued exposure, potential for fetal growth restriction or other subtle effects.
Third Trimester: Risk of extrapyramidal symptoms (e.g., agitation, tremor, hypertonia, hypotonia, somnolence, respiratory distress, feeding disorder) and/or withdrawal symptoms in the neonate. Monitor neonates for these symptoms.
🀱

Lactation

Risperidone and its active metabolite are excreted in human milk. The decision to breastfeed should consider the developmental and health benefits of breastfeeding, the mother’s clinical need for risperidone, and any potential adverse effects on the breastfed infant from risperidone or from the underlying maternal condition. Monitor breastfed infants for sedation, poor feeding, and developmental milestones.

Infant Risk: L3 (Moderate risk). Potential for sedation, irritability, poor feeding, and developmental delay. Monitor infant closely.
πŸ‘Ά

Pediatric Use

Safety and efficacy of risperidone extended-release injectable suspension have not been established in pediatric patients. Oral risperidone is approved for specific pediatric indications (e.g., schizophrenia in adolescents 13-17 years, bipolar mania in adolescents 10-17 years, irritability associated with autistic disorder in children/adolescents 5-16 years).

πŸ‘΄

Geriatric Use

Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Risperidone is not approved for this indication. Increased risk of cerebrovascular adverse events (e.g., stroke, transient ischemic attack) in elderly patients with dementia. Increased sensitivity to orthostatic hypotension and other adverse effects. Use lower initial doses and titrate cautiously.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Risperidone ER injection requires 3 weeks of oral risperidone co-administration after the first injection to ensure therapeutic levels are reached.
  • The injection must be administered deep intramuscularly into the deltoid or gluteal muscle, alternating sites.
  • Do not administer intravenously.
  • Patients should be monitored for metabolic side effects (weight gain, hyperglycemia, dyslipidemia) and movement disorders (EPS, TD).
  • Hyperprolactinemia is a common side effect and can lead to sexual dysfunction, amenorrhea, galactorrhea, and gynecomastia.
  • Orthostatic hypotension is a risk, especially during initial titration; advise patients to rise slowly.
  • This formulation is beneficial for patients with adherence challenges to daily oral medication.
πŸ”„

Alternative Therapies

  • Other atypical antipsychotics (e.g., olanzapine, quetiapine, aripiprazole, ziprasidone, lurasidone, cariprazine, brexpiprazole)
  • Other long-acting injectable antipsychotics (e.g., paliperidone palmitate, olanzapine pamoate, aripiprazole lauroxil)
  • Typical antipsychotics (e.g., haloperidol, fluphenazine)
πŸ’°

Cost & Coverage

Average Cost: $1,000 - $2,500+ per 2-week injection
Generic Available: Yes
Insurance Coverage: Tier 3 or Tier 4 (Specialty Drug)
πŸ“š

General Drug Facts

If your symptoms or health problems persist or worsen, it is essential to contact your doctor for further guidance. To ensure safe use, never share your medication with others, and do not take medication prescribed to someone else. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Dispose of unused or expired medications properly. Unless instructed to do so by a healthcare professional, do not flush medications down the toilet or pour them down the drain. If you are unsure about the correct disposal method, consult your pharmacist for advice. Many communities have drug take-back programs, which your pharmacist can help you locate. Some medications may come with an additional patient information leaflet; check with your pharmacist to see if this applies to your prescription. If you have any questions or concerns about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. Be prepared to provide information about the medication taken, the amount, and the time it was taken to ensure prompt and effective treatment.